retatrutide case study Since January 2026, there have been six cases of acute liver toxicity associated with unapproved peptide products labelled in Australia. These toxic effects may be linked to a contaminant in the Retatrutide (RETA-10) 112mg Research Peptide

One study found that increasing carnitine levels helped to balance the macrophages in the bone marrow, resulting in a more balanced breakdown and rebuilding of bone

The research peptide form requires reconstitution with bacteriostatic water before use, similar to other injectable peptides

So, semaglutide, tirzepatide, and other GLP-1 and GIP analogues are drugs that have demonstrated unmatched effectiveness in the medical treatment of obesity and related potentially fatal diseases and complications

Cheng Y, Xu T, Li S, Ruan H

4.1.3 Safety of GLP-1 receptor agonist therapy in SID GLP-1 RAs and dual GIP/GLP-1 RAs are proven safe in T2DM (44)